NCT03676036View on ClinicalTrials.gov

Efficacy and Steroid Sparing Potential Study of DGLA Cream in Patients With Moderate to Severe Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

March 31, 2018

Study Completion Date

July 31, 2018

Conditions
Atopic Dermatitis
Interventions
DRUG

DS107E

DRUG

Vehicle

Trial Locations (1)

Unknown

DS Biopharma Investigational Site, Lübeck

Sponsors

Lead Sponsor

DS Biopharma
All Listed Sponsors
lead

DS Biopharma

INDUSTRY